These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

253 related items for PubMed ID: 12796792

  • 1. Lack of clinical utility of minimal residual disease detection in allogeneic stem cell recipients with childhood acute lymphoblastic leukemia: multi-institutional collaborative study in Japan.
    Imashuku S, Terui K, Matsuyama T, Asami K, Tsuchiya S, Ishii E, Kawa K, Kosaka Y, Eguchi H, Tsuchida M, Ikuta K, Kato S, Koizumi S, Okamura J, Morimoto A, Hibi S, Hamaoka K, multi-institutional collaborative study in Japan.
    Bone Marrow Transplant; 2003 Jun; 31(12):1127-35. PubMed ID: 12796792
    [Abstract] [Full Text] [Related]

  • 2. Detectable minimal residual disease before allogeneic hematopoietic stem cell transplantation predicts extremely poor prognosis in children with acute lymphoblastic leukemia.
    Sramkova L, Muzikova K, Fronkova E, Krejci O, Sedlacek P, Formankova R, Mejstrikova E, Stary J, Trka J.
    Pediatr Blood Cancer; 2007 Jan; 48(1):93-100. PubMed ID: 16521130
    [Abstract] [Full Text] [Related]

  • 3. Monitoring of minimal residual disease by quantitative WT1 gene expression following reduced intensity conditioning allogeneic stem cell transplantation in acute myeloid leukemia.
    Candoni A, Toffoletti E, Gallina R, Simeone E, Chiozzotto M, Volpetti S, Fanin R.
    Clin Transplant; 2011 Jan; 25(2):308-16. PubMed ID: 20412098
    [Abstract] [Full Text] [Related]

  • 4. Assessment of clonal stability of minimal residual disease targets between 1st and 2nd relapse of childhood precursor B-cell acute lymphoblastic leukemia.
    Guggemos A, Eckert C, Szczepanski T, Hanel C, Taube T, van der Velden VH, Graf-Einsiedel H, Henze G, Seeger K.
    Haematologica; 2003 Jul; 88(7):737-46. PubMed ID: 12857551
    [Abstract] [Full Text] [Related]

  • 5. Poor correlation of kinetics between BCR-ABL and WT1 transcript levels after allogeneic stem cell transplantation.
    Uzunel M, Ringdén O.
    Bone Marrow Transplant; 2004 Jan; 33(1):47-52. PubMed ID: 14704656
    [Abstract] [Full Text] [Related]

  • 6. Minimal residual disease monitoring in adult T-cell acute lymphoblastic leukemia: a molecular based approach using T-cell receptor G and D gene rearrangements.
    Gameiro P, Mortuza FY, Hoffbrand AV, Foroni L.
    Haematologica; 2002 Nov; 87(11):1126-34. PubMed ID: 12414341
    [Abstract] [Full Text] [Related]

  • 7. [Significance of dynamic detection of WT1 expression on monitoring minimal residual disease in leukemia patients following allogeneic bone marrow transplantation].
    Gu WY, Chen ZX, Hu SY, Zhu J, Wang ZL, Yan F, Wang W, Cen JN, Shen HL, Qian J.
    Zhonghua Yi Xue Za Zhi; 2005 Feb 23; 85(7):444-7. PubMed ID: 15854547
    [Abstract] [Full Text] [Related]

  • 8. Mixed chimerism in the B cell lineage is a rapid and sensitive indicator of minimal residual disease in bone marrow transplant recipients with pre-B cell acute lymphoblastic leukemia.
    Zetterquist H, Mattsson J, Uzunel M, Näsman-Björk I, Svenberg P, Tammik L, Bayat G, Winiarski J, Ringdén O.
    Bone Marrow Transplant; 2000 Apr 23; 25(8):843-51. PubMed ID: 10808205
    [Abstract] [Full Text] [Related]

  • 9. Prognostic value of minimal residual disease quantification before allogeneic stem-cell transplantation in relapsed childhood acute lymphoblastic leukemia: the ALL-REZ BFM Study Group.
    Bader P, Kreyenberg H, Henze GH, Eckert C, Reising M, Willasch A, Barth A, Borkhardt A, Peters C, Handgretinger R, Sykora KW, Holter W, Kabisch H, Klingebiel T, von Stackelberg A, ALL-REZ BFM Study Group.
    J Clin Oncol; 2009 Jan 20; 27(3):377-84. PubMed ID: 19064980
    [Abstract] [Full Text] [Related]

  • 10. WT1 protein expression in childhood acute leukemia.
    Kerst G, Bergold N, Gieseke F, Coustan-Smith E, Lang P, Kalinova M, Handgretinger R, Trka J, Müller I.
    Am J Hematol; 2008 May 20; 83(5):382-6. PubMed ID: 18161786
    [Abstract] [Full Text] [Related]

  • 11. Detection of minimal residual disease in patients with childhood common acute lymphoblastic leukemia after autologous bone marrow transplantation with ex vivo purging and systemic IL-2 infusion: unsuccessful prediction of subsequent relapse.
    Kiyoi H, Kojima S, Kato K, Matsuyama T, Kodera Y, Ohno R, Naoe T.
    Bone Marrow Transplant; 1995 Sep 20; 16(3):437-42. PubMed ID: 8535317
    [Abstract] [Full Text] [Related]

  • 12. Clonality profile in relapsed precursor-B-ALL children by GeneScan and sequencing analyses. Consequences on minimal residual disease monitoring.
    Germano G, del Giudice L, Palatron S, Giarin E, Cazzaniga G, Biondi A, Basso G.
    Leukemia; 2003 Aug 20; 17(8):1573-82. PubMed ID: 12886245
    [Abstract] [Full Text] [Related]

  • 13. Characterization of clonal immunoglobulin heavy chain and I cell receptor gamma gene rearrangements during progression of childhood acute lymphoblastic leukemia.
    Marshall GM, Kwan E, Haber M, Brisco MJ, Sykes PJ, Morley AA, Toogood I, Waters K, Tauro G, Ekert H.
    Leukemia; 1995 Nov 20; 9(11):1847-50. PubMed ID: 7475273
    [Abstract] [Full Text] [Related]

  • 14. Monitoring minimal residual disease with flow cytometry, antigen-receptor gene rearrangements and fusion transcript quantification in Philadelphia-positive childhood acute lymphoblastic leukemia.
    Thörn I, Botling J, Hermansson M, Lönnerholm G, Sundström C, Rosenquist R, Barbany G.
    Leuk Res; 2009 Aug 20; 33(8):1047-54. PubMed ID: 19157547
    [Abstract] [Full Text] [Related]

  • 15. The detection of wt-1 transcripts is not associated with an increased leukemic relapse rate in patients with acute leukemia after allogeneic bone marrow or peripheral blood stem cell transplantation.
    Elmaagacli AH, Beelen DW, Trenschel R, Schaefer UW.
    Bone Marrow Transplant; 2000 Jan 20; 25(1):91-6. PubMed ID: 10654021
    [Abstract] [Full Text] [Related]

  • 16. [The monitoring of BCR-ABL mRNA by reverse transcription PCR in patients undergoing allogeneic bone marrow transplantation for acute lymphoblastic leukemia with a positive Philadelphia chromosome].
    Román J, Castillejo JA, Jiménez A, Maldonado J, Torres A.
    Med Clin (Barc); 1999 Dec 11; 113(20):779-82. PubMed ID: 10680143
    [Abstract] [Full Text] [Related]

  • 17. Need for an accurate molecular diagnosis to assess the donor origin of leukemia relapse after allogeneic stem cell transplantation.
    Spinelli O, Giussani U, Borleri G, Lazzari M, Michelato A, Dotti G, Barbui T, Rambaldi A.
    Haematologica; 2000 Nov 11; 85(11):1153-7. PubMed ID: 11064467
    [Abstract] [Full Text] [Related]

  • 18. Prolonged persistence of PCR-detectable minimal residual disease after diagnosis or first relapse predicts poor outcome in childhood B-precursor acute lymphoblastic leukemia.
    Steenbergen EJ, Verhagen OJ, van Leeuwen EF, van den Berg H, Behrendt H, Slater RM, von dem Borne AE, van der Schoot CE.
    Leukemia; 1995 Oct 11; 9(10):1726-34. PubMed ID: 7564517
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.